|
|
 |
|
Viewing report
|
|
|
|
BioSphere Medical, Inc. (BSMD) - Financial and Strategic Analysis Review
GlobalData, Sep 2010, Pages: 35
BioSphere Medical, Inc. (BioSphere) is a medical device company engaged in the development, manufacture and marketing of products using embolotherapy techniques. The company’s technologies contain patented bioengineered polymers, which are chemical compounds created through the application of medical science, engineering principles and manufacturing methods. These core technologies are used to produce miniature spherical embolic particles, or microspheres, that are designed to have uniquely beneficial properties for a variety of medical applications. The major embolic products of the company include Embosphere, Embo Gold Microspheres and Microspheres.
BioSphere Medical, Inc. Key Recent Developments
Sep 03, 2010 BioSphere Agrees To Settle Suit Over Merit Medical merger
Jul 23, 2010 BioSphere Names In Class Action By Shareholders: SEC Filing
Feb 10, 2010 BioSphere Reports Total Revenues Of $31.4 Million In 2009
Feb 01, 2010 BioSphere Medical Announces Retirement Of William M. Cousins From Its Board
Oct 28, 2009 BioSphere Reports Revenues Of $7.7 Million In Q3 2009
This comprehensive SWOT profile of BioSphere Medical, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including,
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities - A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note-: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
-The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key
competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered
in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and
efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Customers who bought this item also bought
Merit Medical Systems, Inc. (MMSI) - Financial and Strategic SWOT Analysis Review
AspenBio Pharma, Inc. (APPYD) - Financial and Strategic SWOT Analysis Review
Bio-Rad Laboratories, Inc. Market Share Analysis
BioMarin Pharmaceutical Inc. (BMRN) - Financial and Strategic SWOT Analysis Review
PDL BioPharma, Inc. (PDLI) - Financial and Strategic SWOT Analysis Review
AspenBio Pharma, Inc. (APPY) - Financial and Strategic Analysis Review
BioSante Pharmaceuticals, Inc. (BPAX) - Financial and Strategic SWOT Analysis Review
Bio-Gate Ag (BIG) - Financial and Strategic SWOT Analysis Review
BioCure, Inc. - Product Pipeline Analysis
BioMimetic Therapeutics, Inc. (BMTI) - Financial and Strategic SWOT Analysis Review
|
|
|
|
